Atrial Fibrillation
Conditions
Brief summary
The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg
Detailed description
HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical parameters and characteristics for cases were assessed retrospectively. Follow-up was performed via review of medical reports, phone calls and postal queries. Outcome parameters included rates for all-cause mortality, non-hemorrhagic stroke, myocardial infarction and major bleeding.
Interventions
no intervention is planned.
Sponsors
University Hospital Heidelberg
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* documented atrial fibrillation * availability of at least one hsTnT measurement
Exclusion criteria
* lost to follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| all-cause mortality | 24 months | all-cause mortality during follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| ischaemic stroke | 24 months | ischaemic stroke during follow-up |
| major bleeding | 24 months | major bleeding during follow-up |
| myocardial infarction | 24 months | myocardial infarction during follow-up |
Countries
Germany
Outcome results
None listed